Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit

Journal of Hospital Infection

Volumn 63, Issue 4, 2006, Pages 385-392

  Dupeyron, C ^a   Campillo, B ^b   Richardet, J P ^b   Soussy, C J ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b Hopital Albert Chenevier   (France)

Author keywords

Carriage; Infection; Liver disease; Mupirocin; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTROBAN NASAL; OFLOXACIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE CARRIER; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL SURGERY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; POSTOPERATIVE INFECTION; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; DISEASE RESERVOIRS; FEMALE; HUMANS; INFECTION CONTROL; LENGTH OF STAY; LIVER DISEASES; MALE; MASS SCREENING; METHICILLIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUPIROCIN; NASAL CAVITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 33745902563     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.03.019     Document Type: Article

References (17)

1. Kluytmans J., Van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 (1997) 505-520
2. Von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344 (2001) 11-16
3. Dupeyron C., Campillo B., Mangeney N., Bordes M., Richardet J.P., and Leluan G. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infection. Infect Control Hosp Epidemiol 22 (2001) 427-432
4. Campillo B., Dupeyron C., and Richardet J.P. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127 (2001) 443-450
5. Laupland K., Church D., Mucenski M., Sutherland L., and Davies H. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 187 (2003) 1452-1459
6. Desai D., Desai N., Nightingale P., Elliot T., and Neuberger J. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl 9 (2003) 754-759
7. Dupeyron C., Campillo B., Bordes M., Faubert E., Richardet J.P., and Mangeney N. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a gastroenterology unit. J Hosp Infect 52 (2002) 281-287
8. Martin J.N., Perdreau-Remington F., Kartalija M., et al. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis 180 (1999) 896-899
9. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002) 1871-1877
10. Paterson D.L., Rihs J.D., Squier C., Gayowski T., Sagnimeni A., and Singh N. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 75 (2003) 194-198
11. Wertheim H.F.L., Vos M.C., Ott A., et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients. Ann Intern Med 140 (2004) 419-425
12. Mody L., Kauffman C.A., McNeil S.A., Galecki A.T., and Bradley S.F. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 (2003) 1467-1474
13. Comité de l'antibiogramme de la Société Française de Microbiologie. Communiqué 2000-2001. Pathol Biol 48 (2000) 832-871
14. Laupland K.B., and Conly J.M. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 37 (2003) 933-938
15. Chang F.Y., Singh N., Gayowski T., Wagener M.M., and Marino I.R. Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect Control Hosp Epidemiol 19 (1998) 328-332
16. Campillo B., Richardet J.P., Kheo T., and Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 35 (2002) 1-10
17. Habarth S., Dharan S., Hiassine N., Herrault P., Auckenthaler R., and Pittet D. Randomized, placebo-controlled, double blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 43 (1999) 1412-1416